gabexate has been researched along with Cancer of Kidney in 2 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tomita, N | 1 |
Kanamori, H | 1 |
Fujita, H | 1 |
Maruta, A | 1 |
Naitoh, A | 1 |
Nakamura, S | 1 |
Ota, Y | 1 |
Nozue, N | 1 |
Kihara, M | 1 |
Ishigatsubo, Y | 1 |
Mikata, N | 1 |
Imao, S | 1 |
Tanaka, Y | 1 |
Horiuchi, D | 1 |
Matsumoto, G | 1 |
Hasegawa, K | 1 |
2 other studies available for gabexate and Cancer of Kidney
Article | Year |
---|---|
Granulomatous tubulointerstitial nephritis induced by all-trans retinoic acid.
Topics: Aged; Benzamidines; Dalteparin; Drug Administration Schedule; Gabexate; Guanidines; Humans; Idarubic | 2001 |
[A case of renal cancer complicated with acute hypercalcemia and acute pancreatitis].
Topics: Acute Disease; Calcitonin; Emergencies; Gabexate; Guanidines; Humans; Hypercalcemia; Kidney Neoplasm | 1989 |